Page 10 of 14 – SEC Filing Scopia
Windmill Fund LP (a) Amount beneficially owned: 1,891,512
(b) Percent of class: 5.18%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote 0 ,
(ii) Shared power to vote or to direct the vote 1,891,512 ,
(iii) Sole power to dispose or to direct the disposition of 0 ,
(iv) Shared power to dispose or to direct the disposition of 1,891,512 .
Scopia Capital GP LLC
(a) Amount beneficially owned: 3,598,222
(b) Percent of class: 9.86%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote 0 ,
(ii) Shared power to vote or to direct the vote 3,598,222
(iii) Sole power to dispose or to direct the disposition of 0 ,
(iv) Shared power to dispose or to direct the disposition of 3,598,222
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| Scopia Windmill Fund LP | ||
| (a) | Amount beneficially owned: | |
| 1,891,512 | ||
| (b) | Percent of class: | |
| 5.18% |
| (c) | Number of shares as to which the person has: | |
| (i) | Sole power to vote or to direct the vote | 0 | , | ||
| (ii) | Shared power to vote or to direct the vote | 1,891,512 | , | ||
| (iii) | Sole power to dispose or to direct the disposition of | 0 | , | ||
| (iv) | Shared power to dispose or to direct the disposition of | 1,891,512 | . |
| Scopia Capital GP LLC |
| (a) | Amount beneficially owned: | |
| 3,598,222 |
| (b) | Percent of class: | |
| 9.86% |
| (c) | Number of shares as to which the person has: | |
| (i) | Sole power to vote or to direct the vote | 0 | , | ||
| (ii) | Shared power to vote or to direct the vote | 3,598,222 | |||
| (iii) | Sole power to dispose or to direct the disposition of | 0 | , | ||
| (iv) | Shared power to dispose or to direct the disposition of | 3,598,222 |
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
Follow Travere Therapeutics Inc. (NASDAQ:TVTX)
Receive real-time insider trading and news alerts


